Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with an IPO date between 2021 and 2023, returning 10,813.2%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 10,813.17% |
Spring Valley Acquisition Corp II Warrant (SVIIW) | 2,496.15% |
DeFi Development (DFDV) | 2,179.68% |
USA Rare Earth (USARW) | 1,228% |
Oncology Institute (TOI) | 1,076.47% |
Abivax SA American Depositary Shares (ABVX) | 1,040.19% |
CEA Industries (BNCWW) | 967.11% |
Wearable Devices (WLDSW) | 820.45% |
BT Brands Inc Warrant (BTBDW) | 797.01% |
Dave Inc Warrants (DAVEW) | 649.53% |
Spring Valley Acquisition Corp II Rights (SVIIR) | 643.75% |
Better Home & Finance (BETR) | 631.95% |
ThredUp (TDUP) | 558.33% |
Oklo (OKLO) | 517.85% |
Eightco (OCTO) | 514.9% |
Asset Entities Inc Class B Common Stock (ASST) | 502% |
Protagenic Therapeutics (PTIXW) | 501.54% |
Mobilicom Limited Warrants (MOBBW) | 496.17% |
TMC the metals (TMC) | 440.35% |
AlphaVest Acquisition Corp Right (ATMVR) | 428.79% |
Spark I Acquisition Corp Warrant (SPKLW) | 407.46% |
Edible Garden (EDBLW) | 401.38% |
IREN (IREN) | 357.23% |
SRM Entertainment, Inc Common Stock (SRM) | 355.27% |
QuantaSing Group Limited American Depositary Shares (QSG) | 341.63% |
